Inovio Pharmaceuticals (INO) Ownership - Who owns Inovio Pharmaceuticals?

Industry: @Medical Specialties

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Medical Specialties

Address

660 West Germantown Pike

Phone

+1 267 440-4200

Employees

122

Web

https://www.inovio.com

Details

Group

Domestic Stock Funds

Fundamentals

INO

Capitalization

284M

P/E Ratio

N/A

Risk (Beta)

1.87

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

13.4M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.03%

Revenue

717K

ROE

N/A

Book Value

94.4M

P/B Ratio

3.00

Cash Flow

N/A

Earnings

-5.51

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

23.4K

Current Ratio

4.77

Current Revenue Per Employee

841.40

Dividends Per Share - Security

N/A

EBITDA

-120.74M

Float

N/A

Float - Current

N/A

Gross Income Margin

100.00

Revenue To Assets

-63.15

Shares Held By Institutions

73.6M

Shares Outstanding - Current

25.9M

Total Liabilities

34.7M

Total Volume MTD

N/A

Value

-1

Gain YTD

78.922

View a ticker or compare two or three

Compare

INO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For INO
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for INO (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of synthetic vaccines and immune therapies for cancers and infectious diseases

Industry Biotechnology